Karen Flynn Insider Profile

4 Followers
Karen Flynn, Sr VP & Chief Commercial Offic at West Pharmaceutical Services, holds 37.12K shares in Catalent (Ticker: CTLT), holds 39.28K shares in Recro Pharma (Ticker: REPH), holds 23.69K shares in West Pharmaceutical Services (Ticker: WST).
tipranks
Karen Flynn

Karen Flynn
West Pharmaceutical Services (WST)
Sr VP & Chief Commercial Offic

Ranked #60,776 out of 78,624 Corporate Insiders

Profitable Transactions

14%
1 out of 7 Profitable Transactions

Average Return

-14.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$10M
63.94%
35.11%
0.95%
A breakdown of Karen Flynn's holdings

Insider Roles

West Pharmaceutical Services
(WST)
Sr VP & Chief Commercial Offic
Catalent
(CTLT)
Pres. Biologics & CCO
Recro Pharma
(REPH)
Director
Roles that Karen Flynn holds in companies

Most Profitable Insider Trade

Stock:
Recro Pharma
(REPH)
Rating:Informative Buy
Date:Dec 19, 2016 - Dec 19, 2017
Return:+36.70%
The most profitable trade made by Karen Flynn

Karen Flynn's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
West Pharmaceutical Services
Feb 21, 2019
Sr VP & Chief Commercial Offic
Uninformative Buy
215.17K
$6.59M
Catalent
Aug 03, 2020
Pres. Biologics & CCO
Uninformative Buy
$3.62M
Recro Pharma
Dec 16, 2019
Director
Uninformative Buy
$98.21K
List of latest transactions for each holding click on a transaction to see Karen Flynn's performance on stock

Karen Flynn insider profile FAQ

What is the percentage of profitable transactions made by Karen Flynn?
The percentage of profitable transactions made by Karen Flynn is 14%.
    What is the average return per transaction made by Karen Flynn?
    The average return per transaction made by Karen Flynn is -14.30%.
      What stocks does Karen Flynn hold?
      Karen Flynn holds: WST, CTLT, REPH stocks.
        What was Karen Flynn’s latest transaction?
        Karen Flynn latest transaction was an Uninformative Buy of ―.
          What was Karen Flynn's most profitable transaction?
          Karen Flynn’s most profitable transaction was an Informative Buy of REPH stock on December 19, 2016. The return on the trade was 36.70%.
            What is Karen Flynn's role in West Pharmaceutical Services?
            Karen Flynn's role in West Pharmaceutical Services is Sr VP & Chief Commercial Offic.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.